A Real-life Population Pharmacokinetic Study Reveals Factors Associated with Clearance and Immunogenicity of Infliximab in Inflammatory Bowel Disease
Brandse, Johannan F, Mould, Diane, Smeekes, Oscar, Ashruf, Yaël, Kuin, Sabine, Strik, Anne, van den Brink, Gijs R, DʼHaens, Geert R
Published in Inflammatory bowel diseases (01.04.2017)
Published in Inflammatory bowel diseases (01.04.2017)
Get full text
Journal Article
Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis
Brandse, Johannan F, Mathôt, Ron A, van der Kleij, Desiree, Rispens, Theo, Ashruf, Yaël, Jansen, Jeroen M, Rietdijk, Svend, Löwenberg, Mark, Ponsioen, Cyriel Y, Singh, Sharat, van den Brink, Gijs R, D’Haens, Geert R
Published in Clinical gastroenterology and hepatology (01.02.2016)
Published in Clinical gastroenterology and hepatology (01.02.2016)
Get full text
Journal Article
Tu1280 Antibodies to Infliximab, Body Weight and Low Serum Albumin Levels Increase Clearance of Infliximab, a Population Pharmacokinetic Study in 324 IBD Patients
Brandse, Johannan F, Mould, Diane R, Ashruf, Yael K, Smeekes, Oscar S, Lowenberg, M, Ponsioen, Cyriel, van den Brink, Gijs R, D'Haens, Geert R
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2015)
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2015)
Get full text
Journal Article
695 Insufficient Infliximab Exposure Predisposes to Immunogenicity and Enhanced Clearance of Infliximab in IBD
Brandse, Johannan F, Strik, Anne S, Mould, Diane, Ashruf, Yael, Smeekes, Oscar S, Kuin, Sabine, van den Brink, Gijs, D'Haens, Geert R
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2016)
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2016)
Get full text
Journal Article